Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

Cell Growth Regulation Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892-4330, USA.
Oncogene (Impact Factor: 8.56). 12/2008; 27 Suppl 2:S31-42. DOI: 10.1038/onc.2009.351
Source: PubMed

ABSTRACT The study of acute-transforming retroviruses and their oncogenes and of the multiple mechanisms deployed by DNA viruses to circumvent the growth-suppressive and proapoptotic function of tumor suppressor genes has provided the foundation of our current understanding of cancer biology. Unlike acute-transforming animal viruses, however, human tumor-associated viruses lead to malignancies with a prolonged latency and in conjunction with other environmental and host-related cooperating events. The relevance of viral infection to human cancer development has often been debated. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), human T-cell lymphotropic virus (HTLV-1) and Kaposi's associated sarcoma virus (KSHV) contribute to 10-15% of the cancers worldwide. Hence, the opportunity exists to fight cancer at the global scale by preventing the spread of these viruses, by the development and distribution of effective and safe antiviral vaccines, and by identifying their oncogenic mechanism. Here, we discuss the molecular events underlying the neoplastic potential of the human tumor-associated viruses, with emphasis on the enigmatic KSHV and its numerous virally hijacked proangiogenic, immune-evasive and tumor-promoting genes. The emerging information may facilitate the development of new molecular-targeted approaches to prevent and treat virally associated human malignancies.

Download full-text


Available from: J. Silvio Gutkind, May 12, 2014
  • Source
    • "Regarding HPV, more than 130 HPV types have been identified and are classified into low-and high-risk groups depending on their likelihood of inducing cervical cancer [12]. Of the individuals infected with HPV, 10–20% will develop cancer of the cervix, anus, vulva, penis and of the head and neck area and oropharynx [1] [4] [13]. HPV is associated with nearly all the carcinomas of the uterine cervix with 70% of the cervical cancers associated with the high-risk HPV types 16 and 18 [12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oncovirus, synonymously called a 'tumour virus', is a virus that can cause cancer. An oncolytic virus preferentially infects the host's cancer cells and lyses them, causing tumour destruction, and is thus referred to as a 'cancer killing virus'. With an estimated 11% of cancer-associated deaths caused by oncoviruses and the possibility that many cancers may be treated by using oncolytic viruses, the role of viruses in cancer may be viewed as a double-edged sword. A total of seven human cancer viruses have been identified as oncoviruses, having been associated with various cancers. Conversely, a large number of oncolytic viruses have shown great potential towards the treatment of certain types of cancer. Proteomics has now been applied towards understanding the complex interplay that exists between oncoviruses and the immune responses that serve to prevent oncoviral diseases. This review attempts to summarise the neoplastic potential of human tumour associated viruses and associated vaccine successes. The potential use of oncolytic viruses for the therapeutic intervention of cancer will also be discussed. Finally, this review will discuss the enormous potential of proteomics technology in the field of oncovirology.
    Proteomics 07/2012; 12(13):2127-38. DOI:10.1002/pmic.201100526 · 3.97 Impact Factor
  • Source
    • "Although in some cases the evidence for causation is less than compelling, other bacterial and parasitic infections have been suggested to be involved in other cancers (Burnett-Hartman et al, 2008; Samaras et al, 2010). Several in-depth reviews exist on infections in general and viral infections in particular as cancer-causing agents (Vousden & Farrell, 1994; zur Hausen, 1999; Parkin, 2006; Boccardo & Villa, 2007; Carrillo-Infante et al, 2007; Martin & Gutkind, 2009; Ziegler & Buonaguro, 2009; Ott et al, 2010; Saha et al, 2010). It is not the intention of this article to replicate the depth of coverage offered elsewhere. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Denis Parsons Burkitt was born in 1911, and in the late 1950s, described the disease that has come to be known as Burkitt lymphoma based on cases he observed in Uganda. Subsequently, Burkitt lymphoma was recognized as the first human tumour associated with an infectious agent when Epstein-Barr virus was isolated from samples supplied by Burkitt. It is now recognized that over one-quarter of cancers worldwide are tied to infections. Notably, liver cancer is linked to hepatitis B virus and hepatitis C virus infections, and cervical cancer to infections involving the human papilloma viruses. In addition, immunocompromise arising from infection with the human immunodeficiency virus allows tumours (e.g., Kaposi sarcoma) caused by other viruses to arise. More than 50 years after the seminal paper by Burkitt based on his work in Africa, it is appreciated that the contribution of viral infections to cancers remains considerably higher in sub-Saharan Africa than in the rest of the world.
    British Journal of Haematology 03/2012; 156(6):709-18. DOI:10.1111/j.1365-2141.2011.09017.x · 4.96 Impact Factor
  • Source
    • "Critical role in EBV-induced transformation plays interaction between cytoplasmic carboxyl terminus of LMP1 and tumor necrosis factor receptor-associated factor and the tumor necrosis factor receptor-associated death domain protein (Brown et al. 2001). These interactions induce the activation of several key signaling molecules such as PI3K, JNK, and JAKs leading to the activation of transcription factors including NFκB, AP-1, and STATs (Kilger et al. 1998), which have been extensively related to human malignancies (Martin and Gutkind 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: About 15-20% of human cancers worldwide have viral etiology. Emerging data clearly indicate that several human DNA and RNA viruses, such as human papillomavirus, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, hepatitis B virus, hepatitis C virus, and human T-cell lymphotropic virus, contribute to cancer development. Human tumor-associated viruses have evolved multiple molecular mechanisms to disrupt specific cellular pathways to facilitate aberrant replication. Although oncogenic viruses belong to different families, their strategies in human cancer development show many similarities and involve viral-encoded oncoproteins targeting the key cellular proteins that regulate cell growth. Recent studies show that virus and host interactions also occur at the epigenetic level. In this review, we summarize the published information related to the interactions between viral proteins and epigenetic machinery which lead to alterations in the epigenetic landscape of the cell contributing to carcinogenesis.
    Clinical Epigenetics 08/2011; 2(2):233-47. DOI:10.1007/s13148-011-0026-6 · 6.22 Impact Factor
Show more